Condensed Consolidated Statements of Stockholders Equity (Deficit) - USD ($) $ in Thousands	Common stock	Additional paid-in capital	Accumulated deficit	Total
Balance at Feb. 28, 2022	$ 7	$ 1,350,431	$ (494,644)	$ 855,794
Balance (shares) at Feb. 28, 2022	67,098,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Settlement of acquisition-related contingent consideration (shares)	1,939,853
Exercise of stock options and vesting of restricted stock units		358		358
Exercise of stock options and vesting of restricted stock units (shares)	228,701
Issuance of common stock in connection with the employee stock purchase plan		1,788		1,788
Issuance of common stock in connection with the employee stock purchase plan (shares)	343,310
Stock-based compensation expense		19,389		19,389
Net loss			(342,822)	(342,822)
Balance at May. 31, 2022	$ 7	1,371,966	(837,466)	534,507
Balance (shares) at May. 31, 2022	69,610,341
Balance at Feb. 28, 2022	$ 7	1,350,431	(494,644)	855,794
Balance (shares) at Feb. 28, 2022	67,098,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(389,345)
Balance at Aug. 31, 2022	$ 7	1,390,296	(883,989)	506,314
Balance (shares) at Aug. 31, 2022	71,538,377
Balance at May. 31, 2022	$ 7	1,371,966	(837,466)	534,507
Balance (shares) at May. 31, 2022	69,610,341
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Settlement of acquisition-related contingent consideration (shares)	1,327,408
Exercise of stock options and vesting of restricted stock units		816		816
Exercise of stock options and vesting of restricted stock units (shares)	600,628
Stock-based compensation expense		17,514		17,514
Net loss			(46,523)	(46,523)
Balance at Aug. 31, 2022	$ 7	1,390,296	(883,989)	506,314
Balance (shares) at Aug. 31, 2022	71,538,377
Balance at Feb. 28, 2023	$ 7	1,428,073	(954,294)	473,786
Balance (shares) at Feb. 28, 2023	73,089,075
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options and vesting of restricted stock units	$ 1	2,530		2,531
Exercise of stock options and vesting of restricted stock units (shares)	1,895,163
Issuance of common stock in connection with the employee stock purchase plan		1,992		1,992
Issuance of common stock in connection with the employee stock purchase plan (shares)	280,162
Stock-based compensation expense		14,278		14,278
Net loss			(38,409)	(38,409)
Balance at May. 31, 2023	$ 8	1,446,873	(992,703)	454,178
Balance (shares) at May. 31, 2023	75,264,400
Balance at Feb. 28, 2023	$ 7	1,428,073	(954,294)	473,786
Balance (shares) at Feb. 28, 2023	73,089,075
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss				(71,234)
Balance at Aug. 31, 2023	$ 8	1,463,164	(1,025,528)	437,644
Balance (shares) at Aug. 31, 2023	76,081,370
Balance at May. 31, 2023	$ 8	1,446,873	(992,703)	454,178
Balance (shares) at May. 31, 2023	75,264,400
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Release of indemnity shares in connection with acquisition (shares)	28,089
Exercise of stock options and vesting of restricted stock units		565		565
Exercise of stock options and vesting of restricted stock units (shares)	788,881
Stock-based compensation expense		15,726		15,726
Net loss			(32,825)	(32,825)
Balance at Aug. 31, 2023	$ 8	$ 1,463,164	$ (1,025,528)	$ 437,644
Balance (shares) at Aug. 31, 2023	76,081,370